High court rules ‘pay-for-delay’ drug deals can face antitrust suits

June 18, 2013

A brand-name drug maker can be sued for violating antitrust laws if it agrees to pay a potential competitor to delay selling a generic version, the Supreme Court ruled. (Los Angeles Times)